Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Evaluation of thiol-disulfide homeostasis in active ankylosing spondylitis patients
Medeni Arpa; Bayram ¿en; Münevver Serdaro¿lu Beyazal; Özcan Erel;
Reumatol Clin. 2022;18:343-8
Changes in immature granulocyte levels and their association with disease activation following biologic therapy in patients with ankylosing spondylitis
Burak Okyar; Servet Yüce; ¿brahim Halil Bilen; Bekir Torun; ¿lyas Öztürk; Gözde Y¿ld¿r¿m Çetin;
Reumatol Clin. 2024;20:533-8
Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease?
Fatih Albayrak; Mustafa Gür; Ahmet Karata¿; Süleyman Serdar Koca; Bünyamin K¿sac¿k;
Reumatol Clin. 2024;20:123-7